| CASE REPORT |
|
| Year : 2023 | Volume
: 3
| Issue : 2 | Page : 436-438 |
|
|
A case of choroidal neovascular membrane in Best vitelliform macular dystrophy treated with intravitreal brolucizumab
Pradeep K Panigrahi, Yamijala Neha Srija, Japesh Thareja, Jasmita Satapathy, Anita Minj
Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan (Deemed to be) University, Bhubaneswar, Odisha, India
Correspondence Address:
Pradeep K Panigrahi
Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhubaneswar - 751 003, Odisha
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/IJO.IJO_2534_22
|
|
|
A 21-year-old healthy male presented with loss of vision associated with metamorphopsia in the right eye of 6 weeks duration. The patient was a known case of best vitelliform macular dystrophy in both eyes. Clinical and imaging studies lead to a diagnosis of the choroidal neovascular membrane (CNVM). The diseased eye was treated with a single dose of intravitreal brolucizumab. Significant gains in visual acuity and reduction in the subretinal fluid were noted over 2 months of follow-up. Intravitreal brolucizumab can be an effective option in treating CNVMs associated with macular dystrophy.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
